UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 301

Sortiert nach

Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells

Leukemia, 2017-09, Vol.31 (9), p.1951-1961

2017

Link zum Volltext

Verfügbarkeit prüfen

BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells

Leukemia, 2017-03, Vol.31 (3), p.678-687

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor

Annals of oncology, 2018-08, Vol.29 (8), p.1880-1882

2018

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia polycythemia vera myelofibrosis

Leukemia, 2008-05, Vol.22 (5), p.965-970

2008

Link zum Volltext

Verfügbarkeit prüfen

Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies

Leukemia, 2008-06, Vol.22 (6), p.1117-1124

2008

Link zum Volltext

Verfügbarkeit prüfen

Utility of the World Heath Organization classification criteria for the diagnosis of systemic mastocytosis in bone marrow

Modern pathology, 2009-01, Vol.22 (1), p.50-57

2009

Link zum Volltext

Verfügbarkeit prüfen

The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR -α -expressing cells through caspase-3-mediated cleavage of Mcl-1

Leukemia, 2007-07, Vol.21 (7), p.1395-1404

2007

Link zum Volltext

Verfügbarkeit prüfen

Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis

Leukemia, 2008-06, Vol.22 (6), p.1295-1298

2008

Link zum Volltext

Verfügbarkeit prüfen

Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL)

Leukemia, 2002-06, Vol.16 (6), p.1045-1052

2002

Link zum Volltext

Verfügbarkeit prüfen

Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome

Leukemia, 2001-08, Vol.15 (8), p.1165-1170

2001

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis

Leukemia research, 2009-11, Vol.33 (11), p.1481-1484

2009

Link zum Volltext

Verfügbarkeit prüfen

Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes

Blood, 2000-09, Vol.96 (6), p.2240-2245

2000

Link zum Volltext

Verfügbarkeit prüfen

AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, Has In vitro Activity against Imatinib-Resistant Chronic Myeloid Leukemia

Clinical cancer research, 2005-07, Vol.11 (13), p.4941-4947

2005

Link zum Volltext

Verfügbarkeit prüfen

P033 The JAK kinase inhibitor CP-690,550 supresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation

Leukemia research, 2007, Vol.31, p.S79-S79

2007

Link zum Volltext

Verfügbarkeit prüfen

Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testing

Leukemia, 2001, Vol.15 (1), p.57-61

2001

Link zum Volltext

Verfügbarkeit prüfen

Design of Peptide Enzymes (Pepzymes): Surface-Simulation Synthetic Peptides that Mimic the Chymotrypsin and Trypsin Active Sites Exhibit the Activity and Specificity of the Respective Enzyme

Proceedings of the National Academy of Sciences - PNAS, 1993-09, Vol.90 (17), p.8282-8286

1993

Link zum Volltext

Verfügbarkeit prüfen

Highly Reproducible Detection and Semi-Quantification of Telomerase Activity

BioTechniques, 2001-05, Vol.30 (5), p.930-934

2001

Link zum Volltext

Verfügbarkeit prüfen

Localization and Synthesis of the Hormone-Binding Regions of the Human Thyrotropin Receptor

Proceedings of the National Academy of Sciences - PNAS, 1991-05, Vol.88 (9), p.3613-3617

1991

Link zum Volltext

Verfügbarkeit prüfen

Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor AML cells

Leukemia, 2017-09, Vol.31 (9), p.1951

2017

Link zum Volltext

Verfügbarkeit prüfen

Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes

Cancer, 2002-11, Vol.95 (9), p.1923-1930

2002

Link zum Volltext

Verfügbarkeit prüfen

The clinical significance of tumor necrosis factor-α plasma level in patients having chronic lymphocytic leukemia

Blood, 2002-08, Vol.100 (4), p.1215-1219

2002

Link zum Volltext

Verfügbarkeit prüfen

AMN107, a novel aminopyrimidine inhibitor of p190 Bcr‐Abl activation and of in vitro proliferation of Philadelphia‐positive acute lymphoblastic leukemia cells

Cancer, 2005-09, Vol.104 (6), p.1230-1236

2005

Link zum Volltext

Verfügbarkeit prüfen

High Expression of the Receptor Tyrosine Kinase Tie-1 in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Leukemia & lymphoma, 2001, Vol.42 (3), p.511-516

2001

Link zum Volltext

Verfügbarkeit prüfen

Myelodysplastic syndrome is not merely “preleukemia”

Blood, 2002-08, Vol.100 (3), p.791-798

2002

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia

Blood, 2002-03, Vol.99 (6), p.2265-2267

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 301

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(272)
Mit Volltextzugriff
(283)

Publikationsform

Sprache

Englisch
(300)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

Science & Technology
(149)
Humans
(131)
Life Sciences & Biomedicine
(130)
Biological And Medical Sciences
(87)
Medical Sciences
(76)
Oncology
(69)
Hematology
(66)
Hematologic And Hematopoietic Diseases
(63)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(61)
Middle Aged
(57)
Female
(54)
Adult
(53)
Male
(51)
Aged
(50)
Prognosis
(42)
Animals
(34)
Aged, 80 And Over
(31)
Mice
(29)
Mutation
(24)
Janus Kinase 2 - Genetics
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(80)
Leukemia Research
(22)
Cancer
(18)
Cancer Research
(14)
Leukemia
(14)
Clinical Lymphoma, Myeloma And Leukemia
(11)
Clinical Cancer Research
(8)
British Journal Of Haematology
(7)
Cancer Science
(5)
Journal Of Protein Chemistry
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells

BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells

Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor

A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia polycythemia vera myelofibrosis

Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies

Utility of the World Heath Organization classification criteria for the diagnosis of systemic mastocytosis in bone marrow

The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR -α -expressing cells through caspase-3-mediated cleavage of Mcl-1

Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis

Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL)

Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome

Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis

Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes

AMN107, a Novel Aminopyrimidine Inhibitor of Bcr-Abl, Has In vitro Activity against Imatinib-Resistant Chronic Myeloid Leukemia

P033 The JAK kinase inhibitor CP-690,550 supresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation

Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testing

Design of Peptide Enzymes (Pepzymes): Surface-Simulation Synthetic Peptides that Mimic the Chymotrypsin and Trypsin Active Sites Exhibit the Activity and Specificity of the Respective Enzyme

Highly Reproducible Detection and Semi-Quantification of Telomerase Activity

Localization and Synthesis of the Hormone-Binding Regions of the Human Thyrotropin Receptor

Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor AML cells

Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes

The clinical significance of tumor necrosis factor-α plasma level in patients having chronic lymphocytic leukemia

AMN107, a novel aminopyrimidine inhibitor of p190 Bcr‐Abl activation and of in vitro proliferation of Philadelphia‐positive acute lymphoblastic leukemia cells

High Expression of the Receptor Tyrosine Kinase Tie-1 in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Myelodysplastic syndrome is not merely “preleukemia”

Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia

Suchergebnisse filtern